| Trial ID: | L1155 |
| Source ID: | NCT03062176
|
| Associated Drug: |
Anakinra
|
| Title: |
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
|
| Acronym: |
E-HART
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Heart Failure, Systolic|Renal Disease, End Stage|Chronic Kidney Diseases
|
| Interventions: |
DRUG: Anakinra
|
| Outcome Measures: |
Primary: Peak oxygen consumption (PVO2), Peak oxygen consumption during cardiopulmonary exercise, 6 months | Secondary: Heart Failure Hospitalization, Number of participants with a hospitalization for heart failure during the 6 months of treatment, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Virginia Commonwealth University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-04-03
|
| Completion Date: |
2019-05-15
|
| Results First Posted: |
|
| Last Update Posted: |
2019-05-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03062176
|
